|Year : 2019 | Volume
| Issue : 7 | Page : 1127-1132
Screening for Charles Bonnet syndrome: Should the definition be reconsidered?
PremNandhini Satgunam1, Rebecca Sumalini2, Gayathri Chittapu3, Gunasree Pamarthi3
1 Brien Holden Institute of Optometry and Vision Sciences, L V Prasad Eye Institute, Hyderabad, Telangana, India
2 Brien Holden Institute of Optometry and Vision Sciences; Institute of Vision Rehabilitation, L V Prasad Eye Institute, Hyderabad, Telangana, India
3 Work done when at Bausch and Lomb School of Optometry, L V Prasad Eye Institute, Hyderabad, Telangana, India
|Date of Submission||10-Oct-2018|
|Date of Acceptance||07-Feb-2019|
|Date of Web Publication||25-Jun-2019|
Dr. PremNandhini Satgunam
Brien Holden Institute of Optometry and Vision Sciences, L V Prasad Eye Institute, Road No 2, Banjara Hills, Hyderabad - 500 034, Telangana
Source of Support: None, Conflict of Interest: None
Purpose: Charles Bonnet syndrome (CBS) is a condition in which individuals with visual impairment (VI) and with no cognitive deficits experience visual hallucinations, typically with no other sensory hallucinations. Although few isolated case reports of CBS from India have been published, the prevalence for CBS in India is largely unknown. The primary aim of this study was to estimate CBS prevalence in patients with vision impairment visiting a tertiary eye care center. Methods: The study was conducted in two phases. In phase 1, patients with VI, age ≥40 years with presenting visual acuity worse than 20/63 were enrolled. In phase 2, patients with presenting visual acuity worse than 20/63 and/or with binocular visual field loss, age ≥18 years were recruited. A CBS survey was administered only to those who passed a screening test for cognition impairment. Results: A total of 218 patients were screened (phase 1 = 113 and phase 2 = 105). Two-hundred ten patients (mean age ± standard deviation = 49.2 ± 17.3 years, males = 139) were found eligible to complete the CBS survey. Fourteen patients were found to have visual hallucinations. In addition, three other patients had visual hallucinations with associated auditory input to the visual imagery. All patients had complete insight about their hallucinations. Conclusion: Depending on the inclusion criteria, we found the prevalence for CBS in patients with VI to vary between 6.7% to 8.1% (if including patients with auditory input). More investigation is needed to assess the associated role of other sensory inputs (e.g. auditory) with the visual imagery experienced in CBS.
Keywords: Auditory, hallucination, low vision, psychiatry, visual impairment
|How to cite this article:|
Satgunam P, Sumalini R, Chittapu G, Pamarthi G. Screening for Charles Bonnet syndrome: Should the definition be reconsidered?. Indian J Ophthalmol 2019;67:1127-32
|How to cite this URL:|
Satgunam P, Sumalini R, Chittapu G, Pamarthi G. Screening for Charles Bonnet syndrome: Should the definition be reconsidered?. Indian J Ophthalmol [serial online] 2019 [cited 2020 Mar 30];67:1127-32. Available from: http://www.ijo.in/text.asp?2019/67/7/1127/260988
Charles Bonnet Syndrome (CBS) is a condition where an individual with visual impairment (VI) and with intact cognition experiences visual hallucinations with lack of other sensory inputs (e.g., no sound or smell is present)., The visual hallucinations experienced can be simple (e.g., seeing bubbles) or complex (e.g., seeing unicorns), and can be static or kinetic images. Although there is no definitive diagnostic criteria, descriptions have included absence of control over the hallucination, possible disappearance of the hallucination on closing the eyes and having full or partial awareness that the hallucinations experienced are not real., The diagnostic criteria also have varied between the inclusion and exclusion of simple hallucinations.
The pathogenesis for the visual hallucinations in CBS is unclear. Some proposed theories include the deafferentation theory that suggests the visual hallucination arises from the visual association cortex after neuronal damage to the visual pathway. Comparisons similar to patients experiencing a sensation of pain or discomfort at the site of an amputated body part (phantom limb theory) have also been made. CBS is mainly diagnosed through verbal interrogation by the treating clinician, only when the patient complains about hallucinations. This poses a difficulty, as most clinicians do not interrogate proactively and patients also hesitate to present their symptoms for fear of being labelled mentally ill. Thus, the condition remains largely unreported or underreported., Also, as dementia, including Alzheimer's and Parkinson's disease are common in old age, many patients distressingly begin to assume they are developing such mental illness.,
While VI resulting from conditions affecting any of the visual pathway structures can cause CBS, it is very predominant in patients with age-related macular degeneration (AMD),, and other ocular diseases affecting the central vision like cataract. The prevalence of CBS amidst the visually impaired population is higher in the Western population ranging from 11% to 63%.,, On the other hand, the prevalence is lower in East Asian countries varying from 0.4% to 1.4%.,, Social structure and close associations with family and friends have been quoted as reasons for the lower prevalence in the East Asian countries in contrast to an isolated lifestyle of the West. However, it is not known if the lower prevalence is from underreporting in the East Asian countries owing to the social stigma associated with mental illness. Other study design-related differences (e.g. inclusion and exclusion criteria) for CBS could have also accounted for the differences in the prevalence.
Prevalence of CBS in India is unknown. Few isolated case reports of CBS in patients with VI have been mostly documented by psychiatrists in India.,,, Most of these reported patients were treated with psychiatric medications. Although there is no standard treatment for CBS, especially in cases of irreversible vision loss, management for this condition largely includes patient education, counselling, and reassuring the patient., Improving social interaction, and low vision rehabilitation may also alleviate CBS. Benefits of psychiatric medications such as pregabalin, olanzapine, etc., have also been documented. The reports of benefit with medication are also subjective like the diagnosis for this condition. The present study was undertaken to screen and characterize the presentations of CBS in patients with VI visiting a tertiary eye care center in India.
| Methods|| |
A cross-sectional study was undertaken. The study protocol was approved by the Institutional Review Board. The study protocol adhered to the tenets of Declaration of Helsinki. All patients in this study were enrolled with written informed consent. The study period was from December 2013 to March 2014, and patients were recruited during two days of a 6-day working week from the outpatient department. Patients above 40 years of age with visual acuity worse than 20/63 in the better eye were enrolled. Visual acuity values were recorded from their clinical records. Patients with any neurological conditions were excluded. Enrolment of the patients, administering the Rowland Universal Dementia Assessment Scale screening and the CBS survey (see below) were done by two authors. Both the authors read out the instructions and the questions in the same way to avoid any examiner bias. The screening and survey happened during the clinic visit of the patient.
Rowland universal dementia assessment scale screening
All the enrolled patients underwent the Rowland Universal Dementia Assessment Scale screening to rule out cognitive impairment. Questions in Rowland Universal Dementia Assessment Scale were verbally translated to Hindi (official language) or Telugu (regional language) to those patients who did not communicate in English. Rowland Universal Dementia Assessment Scale screening assesses multiple cognitive domains such as body orientation, praxis, drawing, judgement, memory, and language. Rowland Universal Dementia Assessment Scale is not affected by gender and preferred language. Rowland Universal Dementia Assessment Scale has also been found to be appropriate for the sociocultural settings in India over the mini-mental state examination. Only those patients who passed the Rowland Universal Dementia Assessment Scale (score 23 or more out of 30) were administered the CBS survey.
There is no accepted standard survey available to diagnose CBS. We designed a simple survey with nine questions (see Appendix) based on an earlier study conducted in Asia. We pilot tested our survey with few naïve respondents (not actual patients) to check for clarity of the questions. No other validation procedure was undertaken. We designed the survey in English, and translated it to Hindi and Telugu, and back translated with two native speakers of the languages who were also fluent in English.
The first question on the survey asked if the participant has experienced seeing imaginary figures. If they say yes, they were asked to continue answering the rest of the questions. If they answered no, they were asked if they knew of someone who has reported seeing such images. If they answered yes, they were asked to continue answering the rest of the questions (to whatever extent they know). If they answered no, they were asked to stop. We believed that in some instances patients may not be willing to reveal their own hallucination experience for the fear of negative stigma, but may be willing to answer in proxy.
Study Phase II
During the recruitment of patients in the first phase, two patients were referred to us by their treating ophthalmologists who knew about our study. These patients proactively complained of seeing imaginary figures to their ophthalmologists. One patient had glaucoma with advanced field loss and good binocular visual acuity (20/20) because of which he was not enrolled in the study. This patient complained of seeing images of Caucasians walking, with no noise/voice associated with it. The second patient had diabetic retinopathy and binocular visual acuity of 20/25 and therefore was not included. This patient complained of seeing animals and had no other sensory inputs. A third patient with right homonymous hemianopia was seen by the first author for Peli-Prism fitting trial. The patient during the prism trial complained of seeing many people come from the right side and silently cross into his left visual field. He was fully aware that they were imaginary and reported seeing such images in the past ever since his hemianopia. This patient had 20/25 binocular visual acuity. We did not include patients with good visual acuity as per our study protocol. Although association of CBS in the presence of good visual acuity is not common, we found a report of such occurrence as well.
Given that patients with better visual acuity and constricted fields may also have hallucinations, a phase 2 of the study (November 2016 to July 2017) was conducted. This study phase also included patients having visual field loss with otherwise normal visual acuity. Given that CBS was reported in younger individuals, patients aged 18 years and above were also recruited as a part of the second phase of the study. The remaining inclusion criteria and testing protocol were all the same as that followed in the earlier phase of the study. The amended protocol was also approved by the institutional review board. The same set of instructions read out in the earlier study phase was also used in this study phase.
| Results|| |
A total of 218 patients (phase I = 113, phase II = 105) who were approached agreed to participate in the study. No patient refused participation in the study. The results from both the study phases are pooled together. The overall mean age ± standard deviation was 49.2 ± 17.3 years. Most of the patients (210 of the 218) passed the Rowland Universal Dementia Assessment Scale and their results are reported. The ocular conditions of these patients are shown in [Table 1]. The mean age of the males (n = 139) and females (n = 71) were 48.9 ± 17.4 years and 49.7 ± 17.4 years, respectively. The overall mean ± standard deviation of the Rowland Universal Dementia Assessment Scale score was 26.12 ± 2.16. The mean Rowland Universal Dementia Assessment Scale score for males and females were 26.2 ± 2.24 and 25.98 ± 1.99, respectively, and no statistically significant difference (two sample t-test, P = 0·49) was found between them.
|Table 1: The different ocular diseases diagnosed in the 210 patients are shown|
Click here to view
All the 210 patients were administered the CBS survey. No patient reported knowing a friend who has experienced visual hallucinations. Seventeen patients (8.1%) reported experiencing visual hallucination and completed the full survey, four of these patients were from study phase I and 13 patients were from study phase II. Fourteen patients (6.7%) reported seeing visual hallucinations without voice and the other three (1.42%) reported the hallucinations to be associated with voice (2 from phase I). [Table 2] shows the demographics of these 17 patients along with the description of the hallucination they experienced. Only 4 of the patients (24%) had hallucinations that did not involve people, the remaining patients mostly saw human figures in their visual hallucination. Other than human figures, animals were also reported by 5 of the patients (29%). All the 17 patients had full insight about their hallucination. The prevalence for CBS [with 95% confidence interval, CI] thus varied between 6.7% (95% CI: 3.7% to 10.9%) to 8.1% (95% CI: 4.8% to 12.6%), excluding and including the auditory input with the visual hallucination, respectively.
| Discussion|| |
This study is the first to systematically screen for CBS in a tertiary eye care center in India. We found about 6.7% of patients with VI to have CBS at our tertiary eye care center, when we adhere to the existing definition of CBS (presence of visual hallucination alone). If we include the three other patients who reported experiencing visual hallucination along with an auditory input relevant to the visual imagery, the prevalence rises to about 8.1%.
Two independent case reports, interestingly also from India have noticed auditory inputs in CBS patients experiencing visual hallucination. In both these reports, the patient's visual hallucination completely disappeared along with audio input after visual restoration with cataract removal, clinching the diagnosis for CBS. Another report outside of India have also observed such improvements. A diagnostic dilemma for CBS in the presence of auditory hallucination was also reported in two patients in Japan. In all these case reports, it is unclear if the auditory input had any association with the visual imagery. We use the terminology “auditory input” rather than “auditory hallucination” to make a distinction. Auditory hallucination could be reserved for hearing noises/voices in the absence of an external auditory stimulus and in the absence of any other sensorial input. Auditory input to a visual imagery on the other hand is hearing noises/voices that are relevant to the perceived visual hallucination. The three patients in our study who experienced visual hallucination had an auditory input associated with the visual imagery. Therefore, we do not report it as auditory hallucination. Auditory and visual hallucination independent of each other has also been reported in a patient with CBS in the past. The auditory hallucination (similar to CBS) was because of the sensory deprivation of hearing in this patient. It may be of interest to have patients with auditory input to their visual imagery check for hearing loss. We did not do hearing tests in our study patients.
Not all patients with VI develop visual hallucination and not all patients experiencing visual hallucination have an auditory input associated with the visual hallucination. Also, some patients with CBS go on to develop dementia or other psychiatric problems and in some cases, patients with psychiatric/neurological disorders can develop CBS after acquiring a vision disorder. It has also been noted that about 12.8% of patients with VI have visual and auditory hallucination. Given all these different presentations and variations, there may be a need for finer classification of CBS possibly with subtypes. A previous study had described “CBS plus” condition only when additional cognitive impairment is found., A distinction for auditory input without cognitive impairment, however, has not been discussed thus far in the literature.
A meaningful auditory input associated to the source of the visual imagery perhaps has a bearing on the cultural setting. In India, the cultural setting is very different from rest of the countries in the West. Loud traffic noises, crowded people, chatty neighbors, and busy streets are common scenes. Noisy environment is an integral part of the lifestyle and culture, and people are used to these background environmental noises. Environmental and ethnicity influence on hallucinatory experiences are documented to be different., It could be possible that the visual hallucination associated in a cultural setting like India easily predisposes an associated auditory input to the visual imagery. The ethnicity and environmental setting of patients who had both visual and auditory hallucination in the study from USA is not known. A previous study from Singapore reported excluding patients experiencing auditory hallucination even though it was associated with the visual hallucination. The study, however, does not report the number of such exclusions. Further carefully controlled studies will be required to answer the speculation on association between environmental noise levels and auditory input to visual hallucinations in CBS patients.
Higher prevalence of CBS in Western countries,, typically have a large number of patients with AMD or where conducted only on AMD patients. AMD is the leading cause of blindness in the Caucasian population. In countries like India, cataract is a leading cause of VI, evidenced also by the ocular diagnosis of our study population, 46/210 patients had cataract whereas only 3/210 had AMD. Retinitis pigmentosa was the second leading cause of VI (n = 31) in our study cohort. Although different kinds of visual hallucinations have been described in ocular conditions leading to VI because of pathologies occurring at different anatomical levels, it is not known if there is a greater predisposition for CBS to occur in diseases that affects retina rather than in a condition that causes VI because of optical degradation. Comparison of prevalence of CBS between cataract, retinitis pigmentosa, and other retinal and neural conditions (e.g. traumatic brain injury resulting in hemianopia) from homogenous population may give some insights to this question.
We found the Rowland Universal Dementia Assessment Scale screening easy for our patients to understand and perform. Two questions in Rowland Universal Dementia Assessment Scale involve the use of vision. One question instructs the participant to copy a geometric figure and the second question instructs them to copy the examiner performing a hand exercise (praxis). If the visual acuity of the participant is very poor, they may not be able to perform these visual tasks. The worst binocular visual acuity was 20/800 in our study. Most of our study patients struggled to copy the geometric figure exactly; nevertheless, they passed Rowland Universal Dementia Assessment Scale through other domains. The difficulty to copy the geometric figure was not necessarily from vision limitation. We noticed those who had poor literacy level reported they can see the figure, but do not know how to draw it. We did not record the educational levels of our patients in this study. Education bias in Rowland Universal Dementia Assessment Scale has been reported. Future work planning to use Rowland Universal Dementia Assessment Scale to rule out cognitive deficits in patients with VI must consider this limitation. Electronic magnification device may be used to enable the participant to do the drawing task (in cases of vision difficulty), such adaptive technology was not used in this study. Another option could be that Rowland Universal Dementia Assessment Scale can be rescaled, dropping the questions on the visual task; however, such a modification may require revalidation of the Rowland Universal Dementia Assessment Scale screening test. Mini-mental state examination test, while used in several CBS studies also has limitations from visual task, but this test has also been criticized for not being sensitive enough to pick up early dementia.
Visual hallucinations can also be caused by neurological disorders (e.g. Parkinson's disease, Lewy body dementia More Details, Lhermitte's hallucinosis), psychiatric disorders (e.g. delirium, schizophrenia), toxic and metabolic disorders (e.g. drug withdrawal syndrome, endocrine disturbances), and by other miscellaneous conditions (e.g. sleep deprivations, intense emotional experiences). A recent review article reports that most CBS patients could be exhibiting early dementia that is missed, whereas on the other hand misdiagnosing CBS patients resulting in unsuitable therapy is also worrisome. Clearly, there is a great need for understanding, diagnosing, and comanaging CBS patients with a team of multidisciplinary healthcare professionals. Systematic multidisciplinary research will also be valuable to understand this condition in the aging population.
All of the 17 patients in our study had not reported about their visual hallucination to their testing eye care professional. Upon detection, we educated the participant about CBS and also advised them to seek low vision services and increase their social activities.
| Conclusion|| |
In conclusion, we observed that the number of patients with CBS reporting to our tertiary eye care center may be higher than those reported for other Asian countries.,, A larger perhaps multicenter study covering different geographical regions in India can give an accurate estimate for the prevalence of CBS in India. Given that the syndrome can be easily mistaken for dementia or other cognitive impairment, it is important eye care professionals be aware of this condition, identify these patients, and as required comanage them with other healthcare professionals. Information pamphlets on CBS given to patients with VI impairment and or their family members can create greater awareness. At present, we have such information pamphlets in English, Hindi, and Telugu in our clinic. Patients experiencing visual hallucination with associated auditory input should also be investigated carefully under the purview of CBS.
Hyderabad Eye Research Foundation (HERF) for support to author PNS. Information pamphlets on CBS in English and Hindi were shared with us by Mr. Scot Muirden, Director, Charles Bonnet Syndrome Foundation, Australia. Telugu translation of this pamphlet was developed at the Institute for Vision Rehabilitation, LV Prasad Eye Institute. Mr. Scot Muirden and Prof. Jill Keefe for their comments on an earlier version of the manuscript. Ms. S. Banu, our librarian for her help in getting articles. Dr. Subhadra Jalali for patient referral.
Financial support and sponsorship
Hyderabad Eye Research Foundation.
Conflicts of interest
There are no conflicts of interest.
| Appendix|| |
Charles Bonnet Syndrome Survey
Some people with vision problems at times see images that are not real. For example, images of animals may appear when crossing the road. This is normal. We want to know if you have seen (or seeing) such images.
Please answer these questions to your best ability and honesty. Please choose one answer
- Have you seen any imaginary images (e.g. animals, trees, flowers, people, others)?
(a) Yes (b) No
- Do you know any friends who have seen such imaginary images?
(a) Yes (b) No
If the answer for Q. 1 is” No” you can stop else please continue
- For how long have you been seeing these imaginary images?
(a) <6 Months (b) 6--12 Months
(c) >12 Months (d) Not sure
- How often do these imaginary images occur?
(a) Always (b) Sometimes
(c) Rarely (d) Not sure
- Are you bothered by these imaginary images?
(a) Yes (b) No (c) Not always
- When do you see these imaginary images more? When you are:
(a) With your friend/family (b) Alone
(c) Both a and b (d) Not sure
- Do you see these imaginary images in greater detail compared to the surroundings?
(a) Yes (b) No (c) Not sure
- Do these imaginary images go away if you move your eyes or blink?
(a) Yes (b) No
- Do these imaginary images occur with any audio, physical, strange smell, or other unusual sensation?
(a) Yes (b) No
| References|| |
Menon GJ, Rahman I, Menon SJ, Dutton GN. Complex visual hallucinations in the visually impaired: The Charles Bonnet Syndrome. Surv Ophthalmol 2003;48:58-72.
Fernandez A, Lichtshein G, Vieweg WV. The Charles Bonnet syndrome: A review. J Nerv Ment Dis 1997;185:195-200.
Ffytche DH. Visual hallucinations and the Charles Bonnet syndrome. Curr Psychiatry Rep 2005;7:168-79.
Kester EM. Charles Bonnet syndrome: Case presentation and literature review. Optometry 2009;80:360-6.
Schultz G, Melzack R. Visual hallucinations and mental state. A study of 14 Charles Bonnet syndrome hallucinators. J Nerv Ment Dis 1993;181:639-43.
O'Farrell L, Lewis S, McKenzie A, Jones L. Charles Bonnet syndrome: A review of the literature. J Vis Impair Blind 2010:104:261-74.
Zerilli-Zavgorodni T, Bisighini S. Charles Bonnet syndrome: Comprehensive review providing an optometric approach to diagnosis and management. Optom Vis Perf 2014;2:26-38.
Santos-Bueso E, Saenz-Frances F, Serrador-Garcia M, Porta-Etessam J, Martinez-de-la-Casa JM, Garcia-Feijoo J, et al.
Prevalence and clinical characteristics of Charles Bonnet syndrome in Madrid, Spain. Eur J Ophthalmol 2014;24:960-3.
Tan CS, Lim VS, Ho DY, Yeo E, Ng BY, Au Eong KG. Charles Bonnet syndrome in Asian patients in a tertiary ophthalmic centre. Br J Ophthalmol 2004;88:1325-9.
Yacoub R, Ferrucci S. Charles Bonnet syndrome. Optometry 2011;82:421-7.
Vojnikovic B, Radeljak S, Dessardo S, Zarkovic-Palijan T, Bajek G, Linsak Z. What associates Charles Bonnet syndrome with age-related macular degeneration? Coll Antropol 2010;34(Suppl 2):45-8.
Khan JC, Shahid H, Thurlby DA, Yates JR, Moore AT. Charles Bonnet syndrome in age-related macular degeneration: The nature and frequency of images in subjects with end-stage disease. Ophthalmic Epidemiol 2008;15:202-8.
Abbott EJ, Connor GB, Artes PH, Abadi RV. Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet syndrome). Invest Ophthalmol Vis Sci 2007;48:1416-23.
Gold K, Rabins PV. Isolated visual hallucinations and the Charles Bonnet syndrome: A review of the literature and presentation of six cases. Compr Psychiatry 1989;30:90-8.
Teunisse RJ, Cruysberg JR, Verbeek A, Zitman FG. The Charles Bonnet syndrome: A large prospective study in The Netherlands. A study of the prevalence of the Charles Bonnet syndrome and associated factors in 500 patients attending the University Department of Ophthalmology at Nijmegen. Br J Psychiatry 1995;166:254-7.
Crumbliss KE, Taussig MJ, Jay WM. Vision rehabilitation and Charles Bonnet syndrome. Semin Ophthalmol 2008;23:121-6.
Goh D, Subramanian A. Visual hallucinations and eye disease: Why Charles Bonnet syndrome is important to eye care practitioners. Optom Pract 2012;13:127-38.
Shiraishi Y, Terao T, Ibi K, Nakamura J, Tawara A. The rarity of Charles Bonnet syndrome. J Psychiatr Res 2004;38:207-13.
Hou Y, Zhang Y. The prevalence and clinical characteristics of Charles Bonnet syndrome in Chinese patients. Gen Hosp Psychiatry 2012;34:566-70.
Sawant NS, Naik NR. Pregabalin induced remission of Charles Bonnet syndrome. Malays J Psychiatry 2013;22:76-9.
Arun P, Jain R, Tripathi V. Atypical charles bonnet syndrome. Indian J Psychol Med 2013;35:402-4.
] [Full text]
Javadekar A, Javadekar N, Pande N, Mehta S. Case report: Charles Bonnet syndrome (CBS). Indian J Basic Appl Med Res 2012;2:436-7.
Nair AG, Nair AG, Shah BR, Gandhi RA. Seeing the unseen: Charles Bonnet syndrome revisited. Psychogeriatrics 2015;15:204-8.
Teunisse RJ, Cruysberg JR, Hoefnagels WH, Verbeek AL, Zitman FG. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet 1996;347:794-7.
Madill SA, Ffytche DH. Charles Bonnet syndrome in patients with glaucoma and good acuity. Br J Ophthalmol 2005;89:785-6; author reply.
Storey JE, Rowland JT, Basic D, Conforti DA, Dickson HG. The Rowland Universal Dementia Assessment Scale (RUDAS): A multicultural cognitive assessment scale. Int Psychogeriatr 2004;16:13-31.
Iype T, Ajitha BK, Antony P, Ajeeth NB, Job S, Shaji KS. Usefulness of the Rowland universal dementia assessment scale in South India. J Neurol Neurosurg Psychiatry 2006;77:513-4.
Elflein HM, Rudy M, Lorenz K, Ponto K, Scheurich A, Pitz S. Charles Bonnet's syndrome: Not only a condition of the elderly. Graefes Arch Clin Exp Ophthalmol 2016;254:1637-42.
Singh A, Sorensen TL. Charles Bonnet syndrome improves when treatment is effective in age-related macular degeneration. Br J Ophthalmol 2011;95:291-2.
Miyaoka T, Nagahama M, Tsuchie K, Hayashida M, Nishida A, Inagaki T, et al
. Charles Bonnet syndrome: Successful treatment of visual hallucinations due to vision loss with Yi-gan san. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:382-3.
Chedru F, Feldman F, Ameri A, Sales J, Roth M. Visual and auditory hallucinations in a psychologically normal woman. Lancet 1996;348:896.
Russell G, Burns A. Charles Bonnet syndrome and cognitive impairment: A systematic review. Int Psychogeriatr 2014;26:1-13.
Chen JJ. Diagnosis and treatment of psychiatric comorbidity in a patient with charles bonnet syndrome. Case Rep Psychiatry 2014;2014:195847.
Kinoshita Y, Tsuchiya M, Kawakami N, Furukawa TA, Kingdon D. Hallucinations in visually impaired individuals: An analysis of the National Comorbidity Survey Replication. Soc Psychiatry Psychiatr Epidemiol 2009;44:104-8.
Johns LC, Nazroo JY, Bebbington P, Kuipers E. Occurrence of hallucinatory experiences in a community sample and ethnic variations. Br J Psychiatry 2002;180:174-8.
Suhail K, Cochrane R. Effect of culture and environment on the phenomenology of delusions and hallucinations. Int J Soc Psychiatry 2002;48:126-38.
Cummings JL, Miller BL. Visual hallucinations. Clinical occurrence and use in differential diagnosis. West J Med 1987;146:46-51.
[Table 1], [Table 2]